Loading clinical trials...
Loading clinical trials...
COVID-19 International Drug Pregnancy Registry (COVID-PR)
Conditions
Interventions
Antiviral Agents
Monoclonal antibody
Locations
1
United States
Pregistry
Los Angeles, California, United States
Start Date
December 1, 2021
Primary Completion Date
September 30, 2027
Completion Date
September 30, 2027
Last Updated
September 26, 2025
NCT07189936
NCT04525716
NCT03188796
NCT04527315
NCT06355232
NCT05191420
Lead Sponsor
Pregistry
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions